Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Immunotherapy: esophageal and gastric cancer

Ramon De Mello • 3 Jun 2019
ASCO 2019
Gastrointestinal Cancer Nivolumab Pembrolizumab Trastuzumab

Ramon De Mello, MD, PhD, FACP, of the University of Algarve, Faro, Portugal, discusses whether immunotherapy will change prospects in esophageal and gastric cancer at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Ramon De Mello

1:38
Pancreatic cancer: epigenetic regulation of cancer self-renewal
Ramon De Mello • 3 Jun 2019
1:53
Palbociclib & fulvestrant for breast cancer
Ramon De Mello • 3 Jun 2019

Related Videos

1:36
CheckMate 9DW: the future of checkpoint inhibitors in advanced HCC
Laura Williams Goff • 6 Jun 2024
2:32
Choosing efficacious treatment options for hepatocellular carcinoma
Laura Williams Goff • 6 Jun 2024
2:20
ORCHESTRA: tumor debulking in metastatic colorectal cancer
Elske Gootjes • 2 Jun 2024
1:15
ABC-07 : chemotherapy with or without SBRT in cholangiocarcinoma
Laura Williams Goff • 6 Jun 2024
The content of VJOncology is intended for healthcare professionals